Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Lung Neoplasms 4Stomach Neoplasms 3Uterine Cervical Neoplasms 1Smoking 1Recurrence 1Pulmonary Disease, Chronic Obstructive 1Platelet Glycoprotein IV Deficiency 1Pediatric Brain Tumor 1Pancreatic Cyst 1Ovarian Neoplasms 1Osteosarcoma 1Neuroendocrine Tumors 1Neoplasms 1Melanoma 1Lymphoma 1Locally Advanced Pancreatic Cancer 1Gastrointestinal Neoplasms 1Fatty Liver 1Cysts 1Colorectal Neoplasms 1Carcinoma, Non-Small-Cell Lung 1Anus Neoplasms 1Adenocarcinoma 1

Interventions

Gemcitabine 4130-nm albumin-bound paclitaxel 2Tomography, X-Ray Computed 1Pancreatectomy 1Endoscopy 1Electroporation 1Drug Therapy 1Diagnostic Imaging 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Locally Advanced Pancreatic Cancer × Tomography, X-Ray Computed × Clear all
NCT06944587 2025-04-25

NORPACT-3

Oslo University Hospital

Recruiting
400 enrolled
Gastrointestinal

Locally Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡